Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
The Methodist Hospital Research Institute
Psyence Australia Pty Ltd
Dana-Farber Cancer Institute
Pfizer
Tizona Therapeutics, Inc
Essen Biotech
Second Life Therapeutics
Novartis
University of Pittsburgh
Medtronic - MITG
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Institut Claudius Regaud
ModeX Therapeutics, An OPKO Health Company
University of Alabama at Birmingham
Cancer Research UK
Memorial Sloan Kettering Cancer Center
Elevation Oncology
Molecure S.A.
Universidade Federal de Pernambuco
Aurigene Discovery Technologies Limited
Astellas Pharma Inc
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cedars-Sinai Medical Center
Sumitomo Pharma America, Inc.
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Barbara Ann Karmanos Cancer Institute
Canadian Cancer Trials Group
Kineta Inc.
Eastern Cooperative Oncology Group
Janssen Research & Development, LLC
Quadriga Biosciences, Inc.
Imperial College London
Roswell Park Cancer Institute
Pfizer
National Institutes of Health Clinical Center (CC)
Weill Medical College of Cornell University
Hospices Civils de Lyon
Celldex Therapeutics
Celgene
Instituto do Cancer do Estado de São Paulo
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Kansas Medical Center
Amgen
Roswell Park Cancer Institute